Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.915 +0.255 (+5.47%)
Streaming Delayed Price Updated: 3:55 PM EST, Dec 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
21 22 Next >
News headline image
Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships ↗
Nvidia announces partnerships with J&J and GE Healthcare to integrate generative AI into surgery and medical imaging at GTC AI conference. Analysts see potential for revenue growth outside tech sector.... 
Via Benzinga
Topics Artificial Intelligence
News headline image
New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence ↗
 
Via Benzinga
News headline image
Nvidia's Secret Weapon Is Not Just Chips But Investing $1.5B In AI's Rising Stars: Report Unveils CEO Jensen Huang's 10-Year Vision ↗
Additionally, the investments help Nvidia "build out the future ecosystem of businesses that depend on its technology" even as rivals are trying to break into the chipmaker's dominance. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Recursion Announces Plans to Open New Office in London
Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the... 
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Forecasting The Future: 4 Analyst Projections For Recursion Pharmaceuticals ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2024 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
News headline image
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24... 
Via Benzinga
News headline image
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst ↗
The company just made a provocative move in one of its collaborations. 
Via The Motley Fool
News headline image
The Top 7 Small-Cap Stocks to Buy in March 2024 ↗
These top small-cap stocks to buy are set for a strong 2024 as reduced inflation increases their growth prospects. 
Via InvestorPlace
Topics Economy
News headline image
The Top 3 Healthcare Stocks to Buy on Weakness in 2024 ↗
Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy. 
Via InvestorPlace
News headline image
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗
Grand View Research says the global 
Via Talk Markets
News headline image
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? ↗
On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks. 
Via InvestorPlace
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today ↗
The company had attracted much interest due to its heavy use of artificial intelligence, but its latest fundamentals disappointed many. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket ↗
Shares of Beyond Meat, Inc. (NASDAQ: BYND) rose sharply in today’s pre-market trading as the company reported stronger-than-expected sales for its fourth quarter. 
Via Benzinga
News headline image
3D Systems Posts Downbeat Q4 Results, Joins Eventbrite, Lemonade And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
News headline image
What's Going On With Recursion Pharmaceuticals Stock Tuesday? ↗
Recursion reported fourth-quarter revenue of $10.89 million, which missed the consensus estimate of $20.35 million. The clinical stage biotech company reported a quarterly loss of 42 cents per share,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
10+ Stocks, ETFs To Ride On Nvidia's Record-Breaking Success ↗
Shares of NVIDIA Corp rose 15% as quarterly earnings beat forecasts. CEO cites AI's role in company's growth. Tech sector up. ETFs benefit. 
Via Benzinga
Topics Artificial Intelligence ETFs Earnings
News headline image
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Etsy, Inc. 
Via Benzinga
News headline image
These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours? ↗
These companies are focused on next-gen technologies that could help transform the healthcare industry. 
Via The Motley Fool
News headline image
NVIDIA Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
NVIDIA Corporation (NASDAQ: NVDA) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 21, 2024. 
Via Benzinga
News headline image
Nvidia Just Invested in These 5 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch. ↗
See which AI stocks the world's hottest AI chipmaker especially likes. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Did Nvidia Invest in These 5 Artificial Intelligence (AI) Stocks? Should You Buy Them, Too? ↗
Nvidia's 13F revealed some interesting investments. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Recursion to Host Public L(earnings) Call on February 27
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks. ↗
Two of these stocks represent some of the best potential applications for AI technology. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics ↗
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway. 
Via Talk Markets
Topics Artificial Intelligence
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.